York-based Abingdon Health, a lateral flow contract research (CRO) and contract development and manufacturing organisation (CDMO), has completed the acquisition of the CS Lifesciences group (Compliance Solutions).
The business announced the £3.2 million deal earlier this year, as well as a placing to raise £5.2 million.
Compliance Solutions is a consultancy business which specialises in meeting compliance (Quality/ Regulatory/ Clinical) requirements in international In Vitro Diagnostic and medical device markets.
The news follows Abingdon Health’s acquisition of IVDeology.
Chris Yates, CEO, Abingdon Health, said: “We are delighted to welcome Edwin Lindsay and all the Compliance Solutions team to the Abingdon Health group.
“The acquisition of Compliance Solutions deepens and broadens Abingdon’s regulatory service offering allowing us to fully support our customers in bringing their products from idea to commercial success.”
Edwin Lindsay, Managing Director of Compliance Solutions, said: “We are delighted to join the Abingdon group and we look forward to working with the Abingdon team to support our growing customer base across the In Vitro Diagnostic and Medical Device Market.
“The regulatory landscape is going through a period of significant change and the enlarged group is well placed to support customers in navigating this complexity to achieve and maintain successful product registrations.”
.){kind=link}